三达膜(688101) - 2021 Q4 - 年度财报

Financial Performance - The company achieved operating revenue of CNY 1,150,709,066.63 in 2021, representing a year-on-year growth of 31.29%[24]. - Net profit attributable to shareholders reached CNY 247,121,741.23, an increase of 11.41% compared to the previous year[24]. - The net profit after deducting non-recurring gains and losses grew by 18.67% year-on-year, amounting to CNY 218,456,469.44[24]. - Cash flow from operating activities increased significantly by 87.25%, totaling CNY 221,133,458.56[24]. - Basic earnings per share rose to CNY 0.74, reflecting a 12.12% increase from the previous year[25]. - The company's total assets at the end of 2021 were CNY 4,854,631,977.93, a 7.09% increase from the end of 2020[24]. - The weighted average return on equity improved to 7.40%, up by 0.53 percentage points from the previous year[25]. - The company reported a significant increase in investment income from joint ventures compared to the previous year, contributing to the net profit growth[27]. Research and Development - The company is investing in research and development, with a budget allocation of approximately $5 million for the development of advanced water treatment technologies[16]. - Research and development expenses accounted for 4.54% of operating revenue, slightly down from 4.58% in 2020[25]. - The total R&D investment for the year was approximately ¥52.21 million, representing a 30.16% increase compared to the previous year[75]. - The company applied for a total of 35 patents during the reporting period, with 26 patents granted, including 7 invention patents and 19 utility model patents[73]. - The company has developed a comprehensive "RDPA" research and development system focused on membrane technology applications, enhancing its core competitiveness[53]. Market Expansion and Strategy - The company is expanding its market presence in seawater desalination, targeting coastal regions to provide fresh water for residential and industrial use[15]. - The company has set a revenue growth target of 15% for the upcoming fiscal year, driven by new product launches and market expansion initiatives[16]. - The company is actively pursuing strategic partnerships and acquisitions to enhance its technological capabilities and market reach[16]. - The company is expanding its production bases across five locations, including Fujian, to alleviate capacity pressure at the Xiamen facility[35]. - The company plans to expand its market presence in Southeast Asia, targeting a 30% increase in market share within the next two years[158]. Technological Innovation - The company reported a significant focus on membrane technology, including microfiltration, ultrafiltration, nanofiltration, and reverse osmosis, which are essential for water treatment processes[14]. - The company has developed a new graphene membrane technology aimed at enhancing water purification efficiency and reducing operational costs[15]. - The company has innovated various advanced inorganic non-metallic membrane materials and high-performance composite membranes, which can replace imported products and offer superior performance[45]. - The company has established a postdoctoral research station and a provincial membrane separation engineering technology center, focusing on membrane separation technology and new membrane material development since 2002[89]. Corporate Governance and Compliance - The company has not reported any violations of decision-making procedures regarding external guarantees[9]. - The company has received a standard unqualified audit report from the accounting firm[8]. - The internal control system is in place and has been evaluated without significant deficiencies during the reporting period[193]. - The company emphasizes the protection of minority shareholders' rights through its clear and transparent dividend distribution process[189]. - The company has updated its articles of association in accordance with the latest laws and regulations, strengthening the responsibilities of independent directors[197]. Environmental Responsibility - The company is committed to achieving compliance with environmental standards, aiming for a 20% reduction in pollutant discharge from its operations by the end of the next fiscal year[16]. - The company operates multiple key pollutant discharge units across various provinces, including Henan, Hubei, Fujian, and Jiangxi, ensuring compliance with local environmental standards[198]. - The company’s wastewater treatment plants have specific discharge limits, such as CODcr ≤ 912.5 tons/year and ammonia nitrogen ≤ 146 tons/year for Xiaogan San Da Water Co., Ltd.[199]. - The company integrates ESG principles into its business strategy, focusing on sustainable development and environmental responsibility[196]. Shareholder and Investor Relations - The company plans to use part of the raised funds to permanently supplement working capital, as approved in the first temporary shareholder meeting[148]. - The company established good investor relations through various communication channels, including investor calls and website interactions[145]. - All resolutions from the four shareholder meetings held during the reporting period were approved without any rejections[149]. - The company is committed to maintaining transparency in its financial dealings and has adhered to relevant policies regarding shareholding[152]. Operational Efficiency - The company reported a 30% increase in operational efficiency due to the implementation of continuous ion exchange technology in its processes[15]. - The company has implemented upgrades and expansions in its water investment operations, applying membrane technology in several wastewater treatment plants, enhancing both treatment standards and revenue[44]. - The company has established stable partnerships with several domestic and international suppliers for raw materials, ensuring a reliable procurement process[47]. Risks and Challenges - The company faces risks related to technological upgrades and the need for continuous innovation to remain competitive in the membrane technology application industry[92]. - The company is exposed to accounts receivable risks due to slow sales returns and long account aging, particularly in its water investment and operation business[93]. - The ongoing COVID-19 pandemic continues to pose uncertainties that may affect client contracts and marketing budgets[97]. - The company is facing intensified competition in the membrane technology application industry due to the entry of large foreign firms[96].